ADGM

Adagio Medical Holdings, Inc.
CAPPED RATING

Adagio Medical Holdings, Inc. (ADGM) is rated C- (1.9/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Revisions (C+); its weakest is Momentum (F).

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
C+
Factor Score 2.5 / 5.0
Growth
C-
Factor Score 2.1 / 5.0
Profitability
D+
Factor Score 1.8 / 5.0
Momentum
F
Factor Score 0.3 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -0.1
EV / EBITDA -1.0
Rev Growth YoY N/A
Gross Margin 0.0%
Price Return 3M -91.7%
Price Return 12M -93.4%
Catalyst Signal 0.00
Market Cap $1.5M
TTM Revenue N/A
Price / Sales N/A
ROE N/M

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C+ (2.5) C- (2.1) D+ (1.8) F (0.3) C+ (2.6) C- (1.9)
2026-11-10 C+ (2.5) D+ (1.7) D+ (1.7) F (0.3) C+ (2.6) D+ (1.8)
2026-11-03 C+ (2.5) D+ (1.6) D+ (1.8) F (0.3) C+ (2.7) D+ (1.8)
2026-10-27 C+ (2.5) D+ (1.6) D+ (1.8) F (0.4) C+ (2.6) D+ (1.8)
2026-10-20 C+ (2.5) D+ (1.6) D+ (1.8) F (0.6) C+ (2.6) D+ (1.8)
Page 1 of 4